GLPwatch
Specific Clinical Experience Investigation for Long-term Use of Bydureon.
NCT01940770 · Completed
Last updated 2026-05-28This clinical trial studied the long-term safety of Bydureon, a medication for adults with type 2 diabetes, by tracking the occurrence of side effects.
Status Completed The study has finished.
Type Observational
Participants 1,137 people
Who can join all sexes
Timeline Started 2013-10 · est. completion 2019-11
Where 47 sites · Japan
What this study is testing ClinicalTrials.gov NCT01940770 ↗
Description as written by the study sponsor.
To confirm the safety and efficacy of Bydureon in long-term use in Japanese patients with type 2 diabetes mellitus under actual drug use.
| Main thing measured | Adverse event incidence |
|---|---|
| Sponsor | AstraZeneca |
| Conditions studied | Type 2 Diabetes |
| GLP-1 drugs | exenatide |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01940770 ↗